Clinical Trials Browser

Malignant mesenchymal tumor, Hemangiopericytoma, Malignant, Fibrosarcoma, Hemangiosarcoma, Leiomyosarcoma, Liposarcoma, Ovarian Neoplasms, Rhabdomyosarcoma, Sarcoma, Sarcoma, Synovial, Endometrial Neoplasms, Sarcoma, Endometrial Stromal, Sarcoma, Alveolar Soft Part, Neurofibrosarcoma, Gastrointestinal Stromal Tumors, Histiocytoma, Malignant Fibrous

NCT00085475 2012-09-24

Imatinib Mesylate in Treating Patients With Locally Advanced or Metastatic Dermatofibrosarcoma Protuberans or Giant Cell Fibroblastoma

Phase 2 Completed

17 enrolled

Sarcoma

Fibrosarcoma, Sarcoma, Histiocytoma, Malignant Fibrous

NCT00956072 2012-09-24

Imatinib Mesylate With or Without Surgery in Treating Patients With Metastatic Gastrointestinal Stromal Tumor That is Responding to Imatinib Mesylate

Phase 3 Terminated

12 enrolled

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT00039364 2012-07-24

Imatinib Mesylate in Treating Patients With Gliomas

Phase 2 Completed

112 enrolled

CNSSarcoma

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma, Central Nervous System Neoplasms, Glioma, Subependymal, Gliosarcoma

Clinical Trials

Basket 1

ALT GIST

Imatinib Mesylate or Observation Only in Treating Patients Who Have Undergone Surgery for Localized Gastrointestinal Stromal Tumor

Imatinib Mesylate in Treating Patients With HIV-Related Kaposi's Sarcoma

Imatinib Mesylate in Treating Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumor

STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma

Imatinib Mesylate in Treating Patients With Locally Advanced or Metastatic Dermatofibrosarcoma Protuberans or Giant Cell Fibroblastoma

Imatinib Mesylate With or Without Surgery in Treating Patients With Metastatic Gastrointestinal Stromal Tumor That is Responding to Imatinib Mesylate

Imatinib Mesylate in Treating Patients With Gliomas